FDA-Approved Cannabis-Based Drug Shows Promising Results As A Treatment For War Veterans: Study Finds Improvement In Cognitive, Mood, Pain-Related Symptoms
Portfolio Pulse from Rolando García
A new study suggests that Epidiolex, a cannabis-based drug by Jazz Pharmaceuticals, may help alleviate symptoms of Gulf War Illness in veterans. The research shows improvements in cognitive, mood, and pain-related symptoms in rats, indicating potential benefits for human treatment.
September 19, 2024 | 5:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jazz Pharmaceuticals' Epidiolex shows potential in treating Gulf War Illness symptoms, including cognitive and pain-related issues, according to a new study. This could expand the drug's market beyond epilepsy treatment.
The study indicates that Epidiolex, already FDA-approved for epilepsy, may be effective in treating Gulf War Illness symptoms. This could lead to increased demand and market expansion for Jazz Pharmaceuticals, positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90